Prof. Hua Huang 黄华
Chief Physician, Professor
Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Treatment of signet ring cell carcinoma, gastric, cardia, colon, and rectal cancers, and stromal tumors via open, laparoscopic, and robotic surgery. Conversion therapy for advanced gastric cancer. Surgery for soft tissue and retroperitoneal tumors.
Dr. Hua Huang is a Chief Physician, Professor, and Doctor of Surgery. With over 26 years of experience since 1995, Dr. Huang serves as Deputy Director of Gastric Surgery at Fudan University Shanghai Cancer Center. Training includes exchanges at Japan's National Cancer Center Hospital and Seoul National University Hospital. Dr. Huang is a member of the International Gastric Cancer Association.
Professional roles
- Member, Chinese Medical Association
- Standing Committee Member, Shanghai Youth Federation of Medicine and Health
- Leader, Young Expert Working Group of Gastric Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair and Secretary-General, China-Korea Laparoscopic Gastrointestinal Surgery Research Collaboration (CKLASS)
Name order: in Chinese the family name comes first (Huang Hua). Papers usually list the name as Hua Huang or Huang H.
Selected publications
38 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Oncol Rep, 2026 (senior author): [Corrigendum] CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition. PubMed 41508934
- J Cancer Res Clin Oncol, 2023 (senior author): Tumor-infiltrating CD226(+)CD8(+) T cells are associated with postoperative prognosis and adjuvant chemotherapeutic benefits in gastric cancer patients. PubMed 36107244
- J Cancer Res Clin Oncol, 2021 (senior author): Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer. PubMed 33891173
- Oncol Lett, 2018 (senior author): Interleukin-15 suppresses gastric cancer liver metastases by enhancing natural killer cell activity in a murine model. PubMed 30250549
- Oncol Rep, 2017 (senior author): CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition. PubMed 28440473
- Oncotarget, 2017 (senior author): CtBP2 overexpression promotes tumor cell proliferation and invasion in gastric cancer and is associated with poor prognosis. PubMed 28404932
- J Vis Surg, 2016 (first author): Uncut Roux-en-Y reconstruction after totally laparoscopic distal gastrectomy with D2 lymph node dissection for early stage gastric cancer. PubMed 29078434
- World J Gastroenterol, 2015 (first author): Prognostic factors and survival in patients with gastric stump cancer. PubMed 25684953
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion